Investors

“Enterprise AI” market estimates for the mid-2020s span a wide band—on the order of tens of billions of dollars annually in some syndicated models, with CAGR assumptions often in the roughly 20–35% range through the early 2030s. The spread is mostly definitional (software vs. services vs. hardware, geography, and whether copilots count as the same category as legacy ML).

Autonomous / “AI agent” products are a thinner slice today but carry aggressive forward curves in vendor research: 2025–2026 estimates in the single- to low-double-digit billions are common, with some long-range scenarios reaching hundreds of billions by the mid-2030s. Treat long tails as scenario analysis, not fact.

Private-market AI funding has been concentrated in very large rounds: a small set of foundation-model and platform companies capture an outsized share of dollars, while application-layer and early-stage teams compete for the remainder.

For diligence on agent startups, the question is less “is AI funded?” and more “does this team have production proof buyers can trust?”—capital availability and buyer trust are not the same thing.

Surveys show broad experimentation with AI and generative tools, but much less evidence of scaled, EBIT-visible deployment. That gap is where vendor claims run ahead of operator confidence—and where neutral, workflow-grounded validation helps.

Signal sits next to buyers and vendors; other participant types push on the same need for clarity—not the same product, but aligned incentives around evidence.

Signal is an independent validator: buyer-aligned incentives, workflow-backed profiles, and a live-environment bar for startup agent teams that want to list and match to real use cases.

This page is not an offer of securities. For investment discussions, contact the company directly.